Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (DMID17-0111)
Received: 20 March 2021
Accepted: 3 January 2022
First Online: 2 March 2022
: Participants will provide consent (parental consent and participant assent when age-appropriate) in order to participate in the trial (consent and assent forms are provided in Additional files InternalRef removed and InternalRef removed). The protocol has been approved by the Emory University Institutional Review Board (IRB#: 00000239 and the Federal University of Minas Gerais Research Ethics Committee (CAAE#: 29735620.0.0000.5149).
: The authors declare that they have no competing interests.